Legend Biotech Corp. ADR (LEGN) News

Legend Biotech Corp. ADR (LEGN): $64.40

1.01 (+1.59%)

POWR Rating

Component Grades








Add LEGN to Watchlist
Sign Up

Industry: Biotech




#97 of 360

in industry

Filter LEGN News Items

LEGN News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest LEGN News From Around the Web

Below are the latest news stories about LEGEND BIOTECH CORP that investors may wish to consider to help them evaluate LEGN as an investment opportunity.

Q2 2023 Legend Biotech Corp Earnings Call

Q2 2023 Legend Biotech Corp Earnings Call

Yahoo | August 16, 2023

Legend Biotech Reports Second Quarter 2023 Results and Recent Highlights

SOMERSET, N.J., August 15, 2023--Legend Biotech reported its unaudited financial results for the three and six months ended June 30, 2023.

Yahoo | August 15, 2023

Why Earnings Season Could Be Great for Legend Biotech (LEGN)

Legend Biotech (LEGN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Yahoo | August 14, 2023

3 Biotech Stocks Poised to Beat Q2 Earnings Estimates

We look at a few biotech companies, LEGN, KOD, GRTX, which are poised to beat second-quarter earnings estimates.

Yahoo | August 14, 2023

Top 5 Stocks Set to Beat on Earnings Next Week

We have narrowed our search to five stocks that are set to declare earnings results next week. These are: LEGN, TJX, WMT, ONON, BILL.

Yahoo | August 10, 2023

3 Biotech Stocks That Analysts Are Drooling Over

With the medical science realm representing one of the most complex markets, these top analyst biotech picks can be worth your time.

Josh Enomoto on InvestorPlace | August 7, 2023

Legend Biotech to Host Investor Conference Call on Second-Quarter Results

SOMERSET, N.J., August 03, 2023--Legend Biotech will host a call to discuss second-quarter 2023 earnings on August 15, 2023 at 8:00am ET.

Yahoo | August 3, 2023

AMD upgraded, Electronic Arts downgraded: Wall Street's top analyst calls

AMD upgraded, Electronic Arts downgraded: Wall Street's top analyst calls

Yahoo | August 2, 2023

What Makes Legend Biotech Corporation (LEGN) a Unique and Exciting Investment Opportunity?

Baron Funds, an investment management company, released its “Baron Health Care Fund” second quarter 2023 investor letter. A copy of the same can be downloaded here. The fund advanced 9.22% (Institutional Shares) in the quarter compared to a 3.44% gain for the Russell 3000 Health Care Index (benchmark) and an 8.74% gain for the S&P 500 […]

Yahoo | July 25, 2023

This Top-Performing Small-Cap Manager Is Betting Big on China

The Matthews Emerging Markets Small Companies fund has delivered a 15.1% annualized three-year return, landing it in the top 1% of its peers. Here’s what manager Vivek Tanneeru is buying now.

Yahoo | June 29, 2023

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!